Detalhe da pesquisa
1.
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C.
N Engl J Med
; 388(1): 44-54, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546659
2.
A comprehensive analysis of POLE/POLD1 genomic alterations in colorectal cancer.
Oncologist
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38776551
3.
A study to learn how well tucatinib plus trastuzumab works for treating participants with metastatic colorectal cancer, and how safe it is: a plain language summary of the MOUNTAINEER study.
Future Oncol
; 20(8): 409-421, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37941353
4.
Improving survival in metastatic colorectal cancer through optimized patient selection.
Clin Adv Hematol Oncol
; 22 Suppl 4(5): 1-20, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38805297
5.
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study.
Lancet Oncol
; 24(5): 496-508, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142372
6.
Impact of Anti-EGFR Therapies on HER2-Positive Metastatic Colorectal Cancer: A Systematic Literature Review and Meta-Analysis of Clinical Outcomes.
Oncologist
; 28(10): 885-893, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37463037
7.
Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancers.
Hepatology
; 75(1): 43-58, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407567
8.
Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion for Pancreatic Cancer with Low-Volume Peritoneal Metastasis: Results from a Prospective Pilot Study.
Ann Surg Oncol
; 30(1): 395-403, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35972667
9.
Rechallenge With Switching Immune Checkpoint Inhibitors Following Autoimmune Myocarditis in a Patient With Lynch Syndrome.
J Natl Compr Canc Netw
; 21(9): 894-899, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37673116
10.
Real-World Treatment Patterns in Patients With HER2-Amplified Metastatic Colorectal Cancer: A Clinical-Genomic Database Study.
J Natl Compr Canc Netw
; 21(8): 805-812.e1, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37549907
11.
Changes in Prescribing Patterns in Stage III Colon Cancer.
J Natl Compr Canc Netw
; 21(8): 841-850.e4, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37549913
12.
The role of microbiome in pancreatic cancer.
Cancer Metastasis Rev
; 40(3): 777-789, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34455517
13.
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017.
Oncologist
; 27(10): 874-883, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35972334
14.
Circulating tumor DNA (ctDNA) to evaluate minimal residual disease (MRD), treatment response, and posttreatment prognosis in pancreatic adenocarcinoma.
Pancreatology
; 22(6): 741-748, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35725696
15.
Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma.
Oncologist
; 26(7): 569-578, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33555095
16.
Nanoliposomal irinotecan (Nal-IRI)-based chemotherapy after irinotecan -based chemotherapy in patients with pancreas cancer.
Pancreatology
; 21(2): 379-383, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33468394
17.
How quality of life can inform management decisions in later-line metastatic colorectal cancer.
Clin Adv Hematol Oncol
; 19 Suppl 22(10): 1-16, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35289802
18.
Transitioning from second-line to third-line therapy in metastatic colorectal cancer.
Clin Adv Hematol Oncol
; 19 Suppl 3(1): 1-20, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33843898
19.
Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma.
Oncologist
; 25(11): e1681-e1690, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32663355
20.
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Oncologist
; 25(5): 380-e763, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826977